Content about Business Relation

January 8, 2013
Vitamin Shoppe proposed acquisition of Super Supplements delayed

The Vitamin Shoppe's proposed acquisition of Super Supplements has been delayed, the company recently announced.

NORTH BERGEN, N.J. — The Vitamin Shoppe's proposed acquisition of Super Supplements has been delayed, the company recently announced. According to the company, the Federal Trade Commission had notified VSI that it is conducting an investigation into the planned acquisition, noting that the investigation will extend beyond Dec. 31, 2012.

January 7, 2013
Cerberus close to acquiring parts of Supervalu

The breakup of Supervalu to private equity firm Cerberus Capital Management could be announced as soon as Thursday when Supervalu shares third-quarter results with analysts, according to a report in the Wall Street Journal published Friday.

NEW YORK — The breakup of Supervalu to private equity firm Cerberus Capital Management could be announced as soon as Thursday when Supervalu shares third-quarter results with analysts, according to a report in the Wall Street Journal published Friday. 

January 4, 2013
Bloomberg: B&L on sales block for as much as $10 billion

According to a Bloomberg report, Abbott Laboratories, Johnson & Johnson and Sanofi are all potential suitors for Bausch & Lomb's eye care business in a deal that could be valued as high as $10 billion.

NEW YORK — According to a Bloomberg report published Friday morning, Abbott Laboratories, Johnson & Johnson and Sanofi are all potential suitors for Bausch & Lomb's eye care business in a deal that could be valued as high as $10 billion. 

B&L is being shopped by private equity firm Warburg Pincus, which is working with Goldman Sachs Group, Bloomberg reported, and both Abbott and Sanofi have contracted financial advisors as well. 

Other companies who have been invited to bid include Merck and Pfizer. 

December 28, 2012
Emergent BioSolutions secures manufacture and sales rights to pandemic influenza vaccine in U.S.

Emergent BioSolutions announced that it has signed a license agreement with VaxInnate Corporation under which Emergent acquired the exclusive right to manufacture and sell VaxInnate’s pandemic influenza vaccine candidate in the United States.

ROCKVILLE, Md. — Emergent BioSolutions on Friday announced that it has signed a license agreement with VaxInnate Corporation under which Emergent acquired the exclusive right to manufacture and sell VaxInnate’s pandemic influenza vaccine candidate in the United States. 

December 27, 2012
Inter Parfums, Alfred Dunhill ink fragrance deal

Inter Parfums has entered into a 10-year exclusive worldwide fragrance license to create, produce and distribute perfumes and fragrance-related products under the Alfred Dunhill Limited brand.

NEW YORK — Inter Parfums has entered into a 10-year exclusive worldwide fragrance license to create, produce and distribute perfumes and fragrance-related products under the Alfred Dunhill Limited (“Dunhill”) brand.

December 6, 2012
Par distributes authorized generic of AstraZeneca hypertension drug

Par Pharmaceutical Cos. has contracted with AstraZeneca to distribute an authorized generic version of a drug used to treat high blood pressure, Par said.

WOODCLIFF LAKE, N.J. — Par Pharmaceutical Cos. has contracted with AstraZeneca to distribute an authorized generic version of a drug used to treat high blood pressure, Par said.

Par announced that it had entered a supply and distribution agreement through subsidiary Par Pharmaceutical to distribute an authorized generic version of Atacand HCT (i.e., candesartan cilexetil and hydrochlorothiazide) tablets.

An authorized generic is a branded drug marketed under its generic name at a discounted price, usually through a third-party company.

December 3, 2012
Dean Foods to sell Morningstar Foods division to Saputo

Dean Foods has entered into a definitive agreement to sell its Morningstar Foods division to Saputo for $1.45 billion.

DALLAS — Dean Foods has entered into a definitive agreement to sell its Morningstar Foods division to Saputo for $1.45 billion.

Morningstar Foods is a manufacturer of dairy and nondairy extended-shelf-life and cultured products, including creams and creamers, ice cream mixes, whipping cream, aerosol whipped toppings, iced coffee, half and half, value-added milks, sour cream and cottage cheese.

November 28, 2012
Physicians Interactive and McKesson collaborate on electronic voucher program delivered to clinicians

Physicians Interactive and McKesson Patient Relationship Solutions on Tuesday announced a joint collaboration to deliver eCoupon, one of the industry’s first automated pharmaceutical voucher and coupon distribution solution for clinicians who use electronic health records and ePrescribing software.

MARLBOROUGH, Mass. — Physicians Interactive and McKesson Patient Relationship Solutions on Tuesday announced a joint collaboration to deliver eCoupon, one of the industry’s first automated pharmaceutical voucher and coupon distribution solution for clinicians who use electronic health records and ePrescribing software.  

November 27, 2012
Microsoft, NextGen team up on medication-record application

A division of Quality Systems has teamed up with Microsoft to develop and launch what it called the first joint consumer-based mobile healthcare information technology application for the Windows 8 platform.

HORSHAM, Pa. — A division of Quality Systems has teamed up with Microsoft to develop and launch what it called the first joint consumer-based mobile healthcare information technology application for the Windows 8 platform.

November 16, 2012
FTC clears Valeant-Medicis deal

The Federal Trade Commission has approved a deal by Valeant Pharmaceuticals International to buy a Scottsdale, Ariz.-based drug maker.

MONTREAL — The Federal Trade Commission has approved a deal by Valeant Pharmaceuticals International to buy a Scottsdale, Ariz.-based drug maker.

Valeant said the FRC had finished reviewing its planned acquisition of Medicis Pharmaceutical and allowed the waiting period required under merger and acquisition laws to terminate early.

Valeant said the deal is still subject to conditions like the approval of Medicis' stockholders, who will have a special meeting on Dec. 7. Medicis makes drugs for asthma, fungal infections and skin conditions like acne and eczema.

November 16, 2012
Twenty-one years supporting JDRF, Walgreens raises $18 million over that period, $1.3 million in 2012

Walgreens and JDRF on Friday announced that Walgreens' community-based programs helped raise more than $1.3 million in 2012 for JDRF. The year marked the 21st anniversary of Walgreens' participation in JDRF's nationwide campaign to raise funds for research to put an end to diabetes.

NEW YORK — Walgreens and JDRF on Friday announced that Walgreens' community-based programs helped raise more than $1.3 million in 2012 for JDRF. The year marked the 21st anniversary of Walgreens' participation in JDRF's nationwide campaign to raise funds for research to put an end to diabetes.

During the month of July, as part of the Walgreens Way to Well Commitment, customers at more than 7,500 Walgreens stores could make donations of $1 or more at checkout. 

November 15, 2012
MinuteClinic, UT Medicine San Antonio form clinical affiliation

CVS Caremark’s MinuteClinic and UT Medicine San Antonio, the academic medical practice of the School of Medicine at the University of Texas Health Science Center at San Antonio, have entered into a clinical affiliation to enhance access to healthcare services in the region.

WOONSOCKET, R.I. and SAN ANTONIO — CVS Caremark’s MinuteClinic and UT Medicine San Antonio, the academic medical practice of the School of Medicine at the University of Texas Health Science Center at San Antonio, have entered into a clinical affiliation to enhance access to healthcare services in the region.

November 15, 2012
Shipments of generic version of Bontril PDM begins

Initial shipment of a generic appetite suppressant has started, the drug's manufacturer said Thursday.

NORTHVALE, N.J. — Initial shipment of a generic appetite suppressant has started, the drug's manufacturer said Thursday.

Elite Pharmaceuticals announced the initial shipment of phendimetrazine tartrate tablets in the 35-mg strength, a generic version of Valeant's Bontril PDM, under a manufacturing and supply agreement with Mikah Pharma. Actavis, recently acquired by Watson Pharmaceuticals, will distribute the drug as part of a distribution agreement between Mikah and Actavis.

November 14, 2012
NCR Corp., SoloHealth sign three-year health kiosk maintenance contract

NCR Corp. is partnering with health kiosk maker SoloHealth to service interactive consumer healthcare kiosks at retailers as SoloHealth rolls them out around the country, the two companies said Tuesday.

DULUTH, Ga. — NCR Corp. is partnering with health kiosk maker SoloHealth to service interactive consumer healthcare kiosks at retailers as SoloHealth rolls them out around the country, the two companies said Tuesday.

NCR's services group has signed a three-year contract with SoloHealth to provide on-site repairs after the units are installed in what the companies expect to be more than 2,500 retail locations by the middle of 2013.

November 13, 2012
Crossmark portal incorporates Microsoft SQL products

Crossmark has launched a self-service data portal that it said would deliver business insights in real time to manufacturer and retail clients in the consumer goods industry.

REDMOND, Wash. — Crossmark has launched a self-service data portal that it said would deliver business insights in real time to manufacturer and retail clients in the consumer goods industry.

The portal, which uses the Microsoft SQL Server Parallel Data Workhouse, provides sales and marketing channels with access to real-time market data, allowing them to analyze and take advantage of market trends faster than before, the company said.

October 31, 2012
Watson sells Rugby OTC business to Harvard Drug Group for $117 million

Watson Pharmaceuticals on Wednesday announced the sale of its Rugby over-the-counter business to the Harvard Drug Group — a distributor and provider of private-label OTCs and generic prescription products under the Major Pharmaceuticals brand — for approximately $117 million.

PARSIPPANY, N.J. — Watson Pharmaceuticals on Wednesday announced the sale of its Rugby over-the-counter business to the Harvard Drug Group — a distributor and provider of private-label OTCs and generic prescription products under the Major Pharmaceuticals brand — for approximately $117 million.  

"I am confident that Major, with its leadership position as a marketer of OTC products, will be more strategically positioned to maximize the value of the long-known and respected Rugby name," stated Paul Bisaro, president and CEO of Watson.

October 22, 2012
Watson, Actavis divest more drugs as condition for FTC merger approval

Watson Pharmaceuticals and Actavis will have to divest rights to almost two dozen drugs as a condition for U.S. regulatory approval of their $5.6 billion merger announced earlier this year, according to regulatory documents.

NEW YORK – Watson Pharmaceuticals and Actavis will have to divest rights to almost two dozen drugs as a condition for U.S. regulatory approval of their $5.6 billion merger announced earlier this year, according to regulatory documents.

October 17, 2012
Take Care Health Systems develops telehealth offering for Blue Cross and Blue Shield of North Carolina

American Well, Blue Cross and Blue Shield of North Carolina and Walgreens' Take Care Health Systems have collaborated to make telehealth services available to thousands of BCBSNC employees located throughout North Carolina.

CHAPEL HILL, N.C. — American Well, Blue Cross and Blue Shield of North Carolina and Walgreens' Take Care Health Systems have collaborated to make telehealth services available to thousands of BCBSNC employees located throughout North Carolina. The service, called OnlineCareNC, allows BCBSNC employees from home or work to receive a healthcare consultation from credentialed Take Care Health System nurse practitioners, health coaches or nutritionists through two-way video, secure text chat or phone.

October 15, 2012
Humana-Walmart plan open for enrollment for seniors

Walmart and Humana have teamed up again to help Medicare beneficiaries afford their prescriptions. With annual enrollment open until Dec. 7, 2012, for 2013 Medicare plans, the Humana-Walmart Preferred Rx Plan announced that it offers one monthly plan premium of $18.50 a month for beneficiaries in all 50 states and Washington, D.C., regardless of where they live.

BENTONVILLE, Ark. — Walmart and Humana have teamed up again to help Medicare beneficiaries afford their prescriptions. With annual enrollment open until Dec. 7, 2012, for 2013 Medicare plans, the Humana-Walmart Preferred Rx Plan announced that it offers one monthly plan premium of $18.50 a month for beneficiaries in all 50 states and Washington, D.C., regardless of where they live.

October 15, 2012
NASA, Epiomed Therapeutics partner on development of scopolamine nasal spray

NASA's Johnson Space Center and Epiomed Therapeutics have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness.

HOUSTON — NASA's Johnson Space Center and Epiomed Therapeutics have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness. 

October 9, 2012
MinuteClinic expands scope of services

On pace to reach about 1,000 clinic locations by 2016 and a robust team of 1,800 nurse practitioners and physician assistants working tirelessly to provide patients convenient access to quality care, MinuteClinic has demonstrated the integral role that it plays not only within CVS Caremark’s healthcare offering but within the entire U.S. healthcare system.


On pace to reach about 1,000 clinic locations by 2016 and a robust team of 1,800 nurse practitioners and physician assistants working tirelessly to provide patients convenient access to quality care, MinuteClinic has demonstrated the integral role that it plays not only within CVS Caremark’s healthcare offering but within the entire U.S. healthcare system.


October 9, 2012
NewsBytes — Chain Pharmacy, 10/15/12

Drug maker Dr. Reddy’s Labs has launched a generic antibiotic drug, the company said. The India-based company announced the launch of amoxicillin tablets, capsules and oral suspension.

Dr. Reddy's launches antibiotics

October 4, 2012
RxMedic, HBS sign automated dispensing, software agreement

A pharmacy automation equipment manufacturer has signed a deal with a company that makes pharmacy software.

RALEIGH, N.C. — A pharmacy automation equipment manufacturer has signed a deal with a company that makes pharmacy software.

RxMedic Systems and Health Business Systems announced Tuesday that they had signed a preferred business partner agreement. The deal will allow users of HBS' RxAxis pharmacy software system to connect with RxMedic's dispensing technology, including its ADS robot, the companies said, allowing pharmacies to be more accurate, productive and profitable.

October 3, 2012
MinuteClinic becomes participating provider with Tricare in Western states

CVS Caremark’s MinuteClinic has become an in-network provider with TriWest, the Western region plan contractor for Tricare — the healthcare insurance program for Uniformed Service members, retirees and their families.

WOONSOCKET, R.I. — CVS Caremark’s MinuteClinic has become an in-network provider with TriWest, the Western region plan contractor for Tricare — the healthcare insurance program for Uniformed Service members, retirees and their families.

September 25, 2012
Health crisis will expand clinic sites, service

When National Association of Chain Drug Stores president and CEO Steve Anderson earlier this year at NACDS Annual urged pharmacy leaders to be “disruptive innovators,” and new NACDS chairman and Walgreens president and CEO Greg Wasson called on the industry to embrace a holistic view of the total store in improving patient lives, they easily could have submitted Walgreens and its Take Care Health Systems subsidiary as an ideal case study.


When National Association of Chain Drug Stores president and CEO Steve Anderson earlier this year at NACDS Annual urged pharmacy leaders to be “disruptive innovators,” and new NACDS chairman and Walgreens president and CEO Greg Wasson called on the industry to embrace a holistic view of the total store in improving patient lives, they easily could have submitted Walgreens and its Take Care Health Systems subsidiary as an ideal case study.